Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancer
Gerda Hofstetter(Innsbruck Medical University), Robert Zeillinger(University of Vienna), Nicole Concin(Innsbruck Medical University), Arijana Zorić(Ruđer Bošković Institute), Heidi Fiegl(Innsbruck Medical University), Christian Marth(Nordic Society of Gynecologic Oncology), Daniel Reimer(Innsbruck Medical University), Alain G. Zeimet, Neda Slade(Ruđer Bošković Institute), Volker Möbus, G. Daxenbichler, Astrid Berger(Innsbruck Medical University), E. Schuster(Medical University of Vienna), Barbara Holzer(Medical University of Vienna)
Cited by 81
Related Papers
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
|International Journal of Gynecological Cancer|2020|1.9k
Fractionation and turnover of stable carbon isotopes in animal tissues: Implications for ?13C analysis of diet
|Oecologia|1983|1.8k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k